Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma

W. Wick, S. Dettmer, A. Berberich, T. Kessler, I. Karapanagiotou-Schenkel, A. Wick, F. Winkler, E. Pfaff, B. Brors, J. Debus, A. Unterberg, M. Bendszus, C. Herold-Mende, A. Eisenmenger, A. von Deimling, D. Jones, S. Pfister, F. Sahm, and M. Platten. Neuro Oncol, 21 (1): 95-105 (January 2019)
DOI: 10.1093/neuonc/noy161

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Heinrich Debus

Karl Debus

Ludwig Debus

Friedolin Debus

Jutta Debus

Other publications of authors with the same name

Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainC. Geisenberger, A. Mock, R. Warta, C. Rapp, C. Schwager, A. Korshunov, A. Nied, D. Capper, B. Brors, C. Jungk and 17 other author(s). Acta Neuropathol, (May 2015)N2M2 (NOA20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastomaW. Wick, S. Dettmer, A. Berberich, T. Kessler, I. Karapanagiotou-Schenkel, A. Wick, F. Winkler, E. Pfaff, B. Brors, J. Debus and 9 other author(s). Neuro Oncol, (October 2018)Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyE. Pfaff, T. Kessler, G. Balasubramanian, A. Berberich, D. Schrimpf, A. Wick, J. Debus, A. Unterberg, M. Bendszus, C. Herold-Mende and 11 other author(s). Neuro Oncol, 20 (6): 826-837 (May 2018)N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastomaW. Wick, S. Dettmer, A. Berberich, T. Kessler, I. Karapanagiotou-Schenkel, A. Wick, F. Winkler, E. Pfaff, B. Brors, J. Debus and 9 other author(s). Neuro Oncol, 21 (1): 95-105 (January 2019)Individual 3D-printed fixation masks for radiotherapy: first clinical experiences.M. Mattke, D. Rath, M. Häfner, R. Unterhinninghofen, F. Sterzing, J. Debus, and F. Giesel. Int. J. Comput. Assist. Radiol. Surg., 16 (6): 1043-1049 (2021)

BibSonomy

Disambiguation of "Debus, J"